Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder [version 2; referees: 2 approved]
نویسندگان
چکیده
While double-blinding is a crucial aspect of study design in an interventional clinical trial of medication for a disorder with subjective endpoints such as major depressive disorder, psychotherapy clinical trials, particularly cognitive-behavioral therapy trials, cannot be double-blinded. This paper highlights the evidence-based medicine problem of double-blinding in the outcome research of a psychotherapy and opines that psychotherapy clinical trials should be called, “partially-controlled clinical data” because they are not double-blinded. The implications for practice are, 1. For practitioners to be clear with patients the level of rigor to which interventions have been studied, 2. For authors of psychotherapy outcome studies to be clear that the problem in the inability to blind a psychotherapy trial severely restricts the validity of any conclusions that can be drawn, and 3. To petition National Health Insurance plans to use caution in approving interventions studied without double-blinded confirmatory trials as they may lead patients to avoid other treatments shown to be effective in double-blinded trials. Douglas Berger ( ) Corresponding author: [email protected] Berger D. How to cite this article: Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major 2016, :638 (doi: ) Depressive Disorder [version 2; referees: 2 approved] F1000Research 4 10.12688/f1000research.6953.2 © 2016 Berger D. This is an open access article distributed under the terms of the , which Copyright: Creative Commons Attribution Licence permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) declared that no grants were involved in supporting this work. Grant information: Competing interests: No competing interests were disclosed. The author has no financial interests, activities, relationships, and affiliations other than those affiliations listed in the title page of the manuscript. There was no data collected or analyzed for this paper. 27 Aug 2015, :638 (doi: ) First published: 4 10.12688/f1000research.6953.1 Referee Status:
منابع مشابه
Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder
While double-blinding is a crucial aspect of study design in an interventional clinical trial of medication for a disorder with subjective endpoints such as major depressive disorder, psychotherapy clinical trials, particularly cognitive-behavioral therapy trials, cannot be double-blinded. This paper highlights the evidence-based medicine problem of double-blinding in the outcome research of a ...
متن کاملThe Efficacy of Cognitive Behavioral Group-Therapy Alone and plus Family Psycho-Education on the Treatment of Major Depression Disorder Symptoms in Females
Background & Aims: Major depression is one of the common psychiatric disorders imposing negative effects on patients and their families. There are several treatment methods for depression. The purpose of the present study was to determine the effect of combination of cognitive behavioral group therapy, family psycho-education and medication versus medication alone on the improvement of major...
متن کاملEfficacy of Pharmacotherapy and Cognitive Therapy, Alone and in Combination in Major Depressive Disorder
Introduction & Objective: Patients with Major depressive are difficult to treat, and the relative efficacy of medications and cognitive therapy in the treatment of depression is still a matter of deabath. The purpose of this study was to compare the efficacies of antidepressant medication, cognitive therapy and combination of cognitive therapy and antidepressant medication. Materials & Met...
متن کاملDouble blinding requirement for validity claims in cognitive-behavioral therapy intervention trials for major depressive disorder. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial
This paper will focus on problems in the inability to double-blind cognitive-behavioral therapy (CBT) studies for major depressive disorder (MDD), and provides an analysis of a recently published study to show how this problem can lead to faulty conclusions. A study by Hollon et al. published in JAMA Psychiatry that compared an antidepressant medication-only arm with a combined CBT/antidepressa...
متن کاملThe Effect of Mindfulness Based Cognitive Therapy on Quality of life, Behavioral Activation, and Cognitive Emotion Regulation in Women’s with Insufficient Depressive Symptom Disorder
Background: insufficient depressive symptom disorder is a main predictor of Major Depression Disorder. Therefore, the aim of this study was investigation of effect of Mindfulness Based Cognitive Therapy (MBCT) on quality of life, behavioral activation and cognitive emotion regulation in women afflicted insufficient depressive symptom disorder. Methods: this study was Quasi-experimental pretest-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016